These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 9727758)

  • 41. Clinical and laboratory correlations in patients with cystic fibrosis and Pseudomonas aeruginosa infection: The experience of a regional centre.
    Smădeanu R; Moşescu S; Zăpucioiu C; Orăşeanu D
    Pneumologia; 2016; 65(4):201-6. PubMed ID: 29542902
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between Staphylococcus aureus alone or combined with Pseudomonas aeruginosa and the clinical condition of patients with cystic fibrosis.
    Hubert D; Réglier-Poupet H; Sermet-Gaudelus I; Ferroni A; Le Bourgeois M; Burgel PR; Serreau R; Dusser D; Poyart C; Coste J
    J Cyst Fibros; 2013 Sep; 12(5):497-503. PubMed ID: 23291443
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The efficacy and safety of meropenem and tobramycin vs ceftazidime and tobramycin in the treatment of acute pulmonary exacerbations in patients with cystic fibrosis.
    Blumer JL; Saiman L; Konstan MW; Melnick D
    Chest; 2005 Oct; 128(4):2336-46. PubMed ID: 16236892
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pseudomonas aeruginosa in cystic fibrosis patients with c.1652G›A (G551D)-CFTR treated with ivacaftor-Changes in microbiological parameters.
    Millar BC; McCaughan J; Rendall JC; Downey DG; Moore JE
    J Clin Pharm Ther; 2018 Feb; 43(1):92-100. PubMed ID: 29293275
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical effects of sinus surgery and adjuvant therapy in cystic fibrosis patients - can chronic lung infections be postponed?
    Aanaes K; Johansen HK; Skov M; Buchvald FF; Hjuler T; Pressler T; Hoiby N; Nielsen KG; von Buchwald C
    Rhinology; 2013 Sep; 51(3):222-30. PubMed ID: 23943728
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Implementation of a successful eradication protocol for Burkholderia Cepacia complex in cystic fibrosis patients.
    Garcia BA; Carden JL; Goodwin DL; Smith TA; Gaggar A; Leon K; Antony VB; Rowe SM; Solomon GM
    BMC Pulm Med; 2018 Feb; 18(1):35. PubMed ID: 29444656
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of Pseudomonas aeruginosa eradication regimens on chronic colonization and clinical outcomes in pediatric patients with cystic fibrosis.
    Nayir Buyuksahin H; Yalçın E; Emiralioglu N; Hazırolan G; Ademhan Tural D; Ozsezen B; Sunman B; Guzelkas I; Dogru D; Ozcelik U; Kiper N
    Pediatr Int; 2022 Jan; 64(1):e15249. PubMed ID: 36321341
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre.
    Ledson MJ; Gallagher MJ; Jackson M; Hart CA; Walshaw MJ
    Thorax; 2002 Feb; 57(2):142-5. PubMed ID: 11828044
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pseudomonas aeruginosa in children with cystic fibrosis diagnosed through newborn screening: assessment of clinic exposures and microbial genotypes.
    Hayes D; West SE; Rock MJ; Li Z; Splaingard ML; Farrell PM
    Pediatr Pulmonol; 2010 Jul; 45(7):708-16. PubMed ID: 20575089
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pseudomonas cepacia: pulmonary infection in patients with cystic fibrosis.
    Taylor RF; Gaya H; Hodson ME
    Respir Med; 1993 Apr; 87(3):187-92. PubMed ID: 7684530
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Chronic bacterial infection and echocardiographic parameters indicative of pulmonary hypertension in patients with cystic fibrosis].
    Rovedder PM; Ziegler B; Pasin LR; Pinotti AF; Barreto SS; Dalcin Pde T
    J Bras Pneumol; 2008 Jul; 34(7):461-7. PubMed ID: 18695790
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Temocillin in cystic fibrosis: a retrospective pilot study.
    Kent L; Bradley JM; France M; Döring G; Carryn S; Bradbury I; Rendall J; Jones A; Elborn JS
    J Cyst Fibros; 2008 Nov; 7(6):551-4. PubMed ID: 18706868
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Eradication of early Pseudomonas aeruginosa infection.
    Høiby N; Frederiksen B; Pressler T
    J Cyst Fibros; 2005 Aug; 4 Suppl 2():49-54. PubMed ID: 16023416
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibody response to Burkholderia cepacia in patients with cystic fibrosis colonized with Burkholderia cepacia and Pseudomonas aeruginosa.
    Hendry J; Butler S; Elborn JS; Govan JR; Nelson J; Shale DJ; Webb AK
    J Infect; 2000 Mar; 40(2):164-70. PubMed ID: 10841094
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Prevalence of Pseudomonas Aeruginosa Infection Over a Ten-Year Period in Children with Cystic Fibrosis.
    Al Shidhani K; O’Reilly R; Javadpour S; O’Sullivan N; McNally P; Cox DW
    Ir Med J; 2019 Jun; 112(6):946. PubMed ID: 31535835
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: VI. Executive summary.
    Zobell JT; Young DC; Waters CD; Ampofo K; Stockmann C; Sherwin CM; Spigarelli MG
    Pediatr Pulmonol; 2013 Jun; 48(6):525-37. PubMed ID: 23359557
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada.
    Speert DP; Henry D; Vandamme P; Corey M; Mahenthiralingam E
    Emerg Infect Dis; 2002 Feb; 8(2):181-7. PubMed ID: 11897071
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Open label study of inhaled aztreonam for Pseudomonas eradication in children with cystic fibrosis: The ALPINE study.
    Tiddens HA; De Boeck K; Clancy JP; Fayon M; H G M A; Bresnik M; Derchak A; Lewis SA; Oermann CM;
    J Cyst Fibros; 2015 Jan; 14(1):111-9. PubMed ID: 25091537
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methods.
    Pressler T; Karpati F; Granström M; Knudsen PK; Lindblad A; Hjelte L; Olesen HV; Meyer P; Høiby N;
    J Cyst Fibros; 2009 Jan; 8(1):37-42. PubMed ID: 18835753
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management of Pseudomonas aeruginosa lung infection in Danish cystic fibrosis patients.
    Pedersen SS; Jensen T; Høiby N; Koch C; Flensborg EW
    Acta Paediatr Scand; 1987 Nov; 76(6):955-61. PubMed ID: 3425313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.